The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months

Clinical trial NCT00224133 · COMPLETED

Trial details

NCT number: NCT00224133
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2005-09-01
Primary completion: 2007-04-01
Enrollment: 661

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.